Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.255 USD | +1.40% | +8.14% | +14.61% |
02-14 | Transcript : Aytu BioPharma, Inc., Q2 2024 Earnings Call, Feb 14, 2024 | |
02-14 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, vs. Street Est of $21.75M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.61% | 17.87M | |
+30.78% | 695B | |
+26.51% | 568B | |
-4.67% | 361B | |
+19.68% | 330B | |
+3.96% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.86% | 168B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Transcript : Aytu BioPharma, Inc., Q1 2024 Earnings Call, Nov 14, 2023